1 Polen Capital AstraZeneca PLC Trades
Polen Capital acquired 26k AstraZeneca PLC shares worth $4.95M. That's 0.03% of their equity portfolio (59th largest holding). The investor's estimated purchase price is $4.97M, resulting in a loss of 0.5%.
News about AstraZeneca PLC and Polen Capital
AstraZeneca has a 'catalyst-rich' period ahead
British pharmaceuticals megacap AstraZeneca PLC (LSE:AZN) shares surged nearly a percentage point higher on Friday, reflecting what broker Shroe Capital Mark...
3 Undervalued Pharma Stocks to Buy for Dividends and Capital Gains
There are multiple reasons to consider exposure to pharmaceutical stocks for the long-term portfolio. First, pharma stocks have a low-beta and provide and he...
Kerrisdale Capital Slams Altimmune (ALT) Stock in New Short Report
Kerrisdale Capital is at it again, this time revealing a short position in struggling biotech firm Altimmune (NASDAQ: ALT ). The acclaimed short seller has j...
This Analyst Slightly Lowers AstraZeneca Forecast Amid Earnings Concerns, Although Still Bullish on Future Growth Potential
Thursday, AstraZeneca Plc (NASDAQ: AZN ) reported fourth-quarter 2023 sales of $12.02 billion, up 7% Y/Y (+8% at constant currency), slightly below the conse...